Parexel Partners with CTC North to Increase Research Capacity for Delivery of Early Phase Clinical Trials

Read More


Press Releases


In the News


Latest Podcasts

Episode 13: The New Pragmatism: Clinical Trials, Investment and Regulations Post-COVID-19

Once the COVID-19 pandemic passes or is contained, the world will look and work very differently. The biopharmaceutical industry is no exception. In this podcast, Peyton Howell, Parexel’s Chief Commercial and Strategy Officer, talks with Paul Bridges, Worldwide Head of Regulatory and Access, and Sheela Hegde, a Partner with Parexel’s Health Advances subsidiary, about the regulatory, investing and clinical development changes that are most likely here to stay – The New Pragmatism.

The Parexel Podcast | Episode 12: ASCO20 Debrief: The latest in cell and gene therapy

In this podcast, clinical industry experts discuss the progress made in cell and gene therapy as presented at ASCO and how the industry can continue to move these developments forward today and in the future.

The Parexel Podcast | Episode 11: Maintaining Clinical Trial Continuity During COVID-19: The Patient Perspective

In this podcast, we explore how clinical trials have changed and adapted, and how those changes may impact clinical trials in the future for patients. Ken Getz, professor at Tufts University School of Medicine and the Founder and Chairman of the Center for Information and Study on Clinical Research Participation (CISCRP) moderates this discussion on this most important #ICTD2020 featuring three members of Parexel's Patient Advisory Council along with Parexel’s Chief Medical & Scientific Officer, Dr. Sy Pretorius.

Awards & Achievements

Media Resources & Contacts


Lori Dorer

Vice President, Executive & Strategic Communications

T: 978.495.4135
M: 513.496.8121

Becky Levine

Associate Director, Global Public Relations

T: 919.748.6090
M: 919.271.5151

We are always available for a conversation.